Encompass Health Corporation $EHC Shares Bought by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. increased its holdings in Encompass Health Corporation (NYSE:EHC – Free Report) by 114.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,684 shares of the company’s stock after acquiring an additional 7,852 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Encompass Health were worth $1,784,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in EHC. BlackRock Inc. bought a new stake in shares of Encompass Health in the 2nd quarter valued at about $1,059,762,000. William Blair Investment Management LLC purchased a new stake in shares of Encompass Health in the 2nd quarter worth approximately $116,352,000. Allspring Global Investments Holdings LLC lifted its position in shares of Encompass Health by 308.5% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,096,357 shares of the company’s stock worth $130,532,000 after purchasing an additional 827,982 shares during the period. Bank of New York Mellon Corp bought a new position in shares of Encompass Health during the second quarter valued at approximately $81,676,000. Finally, Bank of America Corp DE bought a new position in shares of Encompass Health during the second quarter valued at approximately $79,660,000. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Down 0.1%

NYSE:EHC opened at $140.86 on Monday. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $143.90. The stock has a market capitalization of $13.82 billion, a P/E ratio of 22.01, a P/E/G ratio of 2.44 and a beta of 0.83. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.09 and a current ratio of 1.09. The company’s 50-day simple moving average is $126.70 and its 200-day simple moving average is $112.02.

Encompass Health (NYSE:EHC – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.16. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.60 billion. Encompass Health had a net margin of 10.17% and a return on equity of 18.35%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.23 EPS. On average, equities analysts anticipate that Encompass Health Corporation will post 6.29 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, January 4th. Encompass Health’s dividend payout ratio (DPR) is 13.12%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Truist Financial reissued a “buy” rating and set a $156.00 price objective (up from $150.00) on shares of Encompass Health in a report on Friday, October 30th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Barclays increased their target price on Encompass Health from $144.00 to $151.00 and gave the company an “overweight” rating in a research report on Thursday, October 29th. KeyCorp lifted their price target on Encompass Health from $147.00 to $150.00 and gave the company an “overweight” rating in a report on Friday, October 30th. Finally, TD Cowen boosted their price target on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Encompass Health has a consensus rating of “Buy” and an average target price of $154.25.

Read Our Latest Stock Report on EHC

Insider Transactions at Encompass Health

In other Encompass Health news, EVP John Darby sold 4,858 shares of Encompass Health stock in a transaction on Monday, August 31st. The shares were sold at an average price of $121.09, for a total value of $588,255.22. Following the transaction, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,086,714.69. The trade was a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Profile

(Free Report)

Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries. Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.

Further Reading

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.